Spectrum awards more than $1 million in pilot grants to 30 projects
Stanford’s clinical and translational research center has awarded funding to teams of multidisciplinary investigators who are tackling health-care problems through novel approaches.
Cancer Institute symposium to feature young researchers
Stanford graduate students, postdoctoral scholars and other junior investigators will convene Feb. 23 share their latest research projects and hear advice from established cancer scientists.
Event cancelled: Nancy Snyderman to discuss global health
(Because of weather problems on the East Coast, this event has been cancelled.)…
Faculty members appointed to endowed professorships
Steven Artandi, Linda Boxer, Anne Brunet, Thomas Clandinin, Leonore Herzenberg and Joseph Wu have been appointed to endowed professorships at the School of Medicine.
Medical school opens a new office to help faculty with grant applications
The Stanford Research Development Office is now open to assist in the preparation of grants for large multidisciplinary projects and to help early-career assistant professors write grants.
Memorial event for Herbert Schwartz set for Feb. 5
Schwartz, a professor emeritus and former chair of pediatrics, died Nov. 13.
Neuroscience Health Center opens to patients
The center offers advanced diagnostic testing and treatments, as well as support services, all available in a single, easy-to-navigate building.
Magazine, writers earn top AAMC honors
Stanford Medicine magazine was recognized by its peers at academic medical centers for the quality of the publication and three of the pieces it published.
Stanford scientist Stanley Falkow to receive National Medal of Science
The microbiologist conducted pioneering work in learning how bacteria can cause human disease and how antibiotic resistance spreads.
SRI Biosciences, Stanford Cancer Institute launch drug discovery program
The SRI Biosciences-Stanford Drug Discovery and Development Program was created in response to a significant drop in the early pipeline of innovative new drugs.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.